PIK3CA and colorectal carcinoma: PIK3CA mutations may, however, suggest benefit from aspirin for secondary prevention, since large studies have demonstrated that aspirin reduces adenoma and CRC formation in individuals with PIK3CA-mutated primary CRC [87, 88].